Innovating at Scale: Fireside Chat with Life Sciences Leader Dr. Alexander Moscho

​Introducing Cell to Scale - A New Event Series Spotlighting the Journeys of Founders Behind Groundbreaking Biotechnology Companies, Hosted by One of Europe's Most Prominent Biotech Investors, Nadav Rosenberg.

​For the second event in our series, we are thrilled to feature a special fireside chat with life sciences founder, executive, and investor, Dr. Alexander Moscho.

​Dr. Alexander Moscho brings a wealth of experience, having previously served as an Executive Committee member and Chief Strategy Officer at UCB Pharma, as well as the CEO of Bayer UK/Ireland. With his deep expertise in building partnerships and leading innovation in the biotechnology sector, Dr. Moscho will share his perspectives on scaling biotech ventures, the future of the industry, and lessons from his remarkable career journey.

​​Hosting the series will be Nadav Rosenberg, founder of Saras Capital, a biotechnology-focused fund in London, and Venture Partner at Entrepreneur First. With a portfolio that includes pioneering companies like Ochre Bio, Core Biogenesis, and Eleven Therapeutics, Nadav’s focus is on backing ambitious scientists and technologists at the earliest stages of their founding journeys. We look forward to seeing you there!

​Agenda:
18:30–19:00: Registration
19:00–20:00: Fireside Chat with Dr. Alexander Moscho
20:00–21:00: Networking and Refreshments